Product NDC: | 49938-101 |
Proprietary Name: | Dapsone |
Non Proprietary Name: | Dapsone |
Active Ingredient(s): | 100 mg/1 & nbsp; Dapsone |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49938-101 |
Labeler Name: | Jacobus Pharmaceutical Company, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA086842 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080815 |
Package NDC: | 49938-101-30 |
Package Description: | 2 BLISTER PACK in 1 CARTON (49938-101-30) > 15 TABLET in 1 BLISTER PACK |
NDC Code | 49938-101-30 |
Proprietary Name | Dapsone |
Package Description | 2 BLISTER PACK in 1 CARTON (49938-101-30) > 15 TABLET in 1 BLISTER PACK |
Product NDC | 49938-101 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dapsone |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20080815 |
Marketing Category Name | ANDA |
Labeler Name | Jacobus Pharmaceutical Company, Inc. |
Substance Name | DAPSONE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Sulfone [EPC],Sulfones [Chemical/Ingredient] |